Phenotypic Properties of Preneoplastic Rat Liver Lesions and Applications to Detection of Carcinogens and Tumor Promoters

1. Bernblum I (1974). Carcinogenesis as a biological problem. In: Frontiers of Biology, A Neuberger and EL Tatum (eds). Elsevier, New York.

2. International Agency for Research on Cancer (1998). Use of Results of Short- and Medium-Term Predictive Tests for Carcinogens and of Data on Genetic and Related Effects in the Evaluation Process Used in the IARC Monographs. International Agency for Research on Cancer Research Report, Scientific Publication, IARC, Lyon, France (in press).

3. Moore JA (1989). Discussion relative to regulatory issues. Toxicol. Pathol 17: 732.

4. Umemura T , Tokumo K , Gebhardt R , Poirier M , and Williams GM (1993). Dose response effects of 2-acetylaminofiuorene on DNA damage, cytotoxicity, cell proliferation and neoplastic conversion in rat liver. Cancer Lett. 73: 1–10.

5. Watanabe K and Williams GM (1978). Enhancement of rat hepa-tocellular-altered foci by the liver tumor promoter phenobarbital: Evidence that foci are precursors of neoplasms and that the pro- moter acts on carcinogen-induced lesions. J. Natl. Cancer Inst. 61: 1311–1314.

6. Williams GM (1978). Enhancement of hyperplastic lesions in the rat liver by the tumor promoter phenobarbital. In: Carcinogenesis, Vol. 2, Mechanisms of Tumor Promotion and Cocarcinogenesis, TJ Slaga , A Sivak , and RK Boutwell (eds). Raven Press, New York, pp. 449–452.

7. Williams GM (1982). Phenotypic properties of preneoplastic rat liver lesions and applications to detection of carcinogens and tumor promoters. Toxicol. Pathol. 10: 3–10.

8. Williams GM (1989). The significance of chemically-induced hepatocellular altered foci in rat liver and application to carcinogen detection. Toxicol. Pathol. 17: 663–674.

9. Williams GM (1998). Chemical-Induced Rodent Preneoplastic Lesions as Indicators of Carcinogenic Activity. International Agency for Research on Cancer Research Report, Scientific Publication, IARC, Lyon, France (in press).

10. Williams GM , Iatropoulos MJ , Djordjevic MV , and Kaltenberg OP (1993). The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat. Carcinogenesis 14: 315–317.

11. Williams GM , Iatropoulos MJ , and Karlsson S (1997). Initiating activity of the antiestrogen tamoxifen but not toremifene in rat liver. Carcinogenesis 18: 2247–2253.

12. Williams GM , Iatropolous MJ , Wang CX , Rivenson A , Peterson LA , Schulz C , and Gebhardt R (1996). Diethylnitrosamine exposure-responses for DNA damage, centrilobular cytotoxicity, cell proliferation and carcinogenesis in rat liver exhibit non-linearities. Carcinogenesis 17: 2253–2258.

13. Williams GM , Klaiber M , Parker SE , and Farber E (1976). Nature of early appearing, carcinogen-induced liver lesions resistant to iron accumulation. J. Natl. Cancer Inst. 57: 157–165.

14. Williams GM and Yamamoto RS (1972). Absence of stainable iron from preneoplastic and neoplastic lesions in rat liver with 8-hydroxyquinoline-induced siderosis. J. Natl. Cancer Inst. 49: 685–694.

15. Yamamoto RS , Williams GM , Frankell HH , and Weisburger JH (1971). 8-Hydroxyquinoline: Chronic toxicity and inhibitory effect on the carcinogenicity of N-2-fluorenylacetamide. Toxicol. Appl. Pharmacol. 19: 687–698.